Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 24519428)

1.

Sildenafil attenuates vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity.

Fawzi AA, Chou JC, Kim GA, Rollins SD, Taylor JM, Farrow KN.

Invest Ophthalmol Vis Sci. 2014 Mar 10;55(3):1493-501. doi: 10.1167/iovs.13-13207.

PMID:
24519428
2.

Increased retinal neovascularization in Fas ligand-deficient mice.

Davies MH, Eubanks JP, Powers MR.

Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3202-10.

PMID:
12824272
3.

CEACAM1 confers resistance toward oxygen-induced vessel damage in a mouse model of retinopathy of prematurity.

Ludewig P, Flachsbarth K, Wegscheid C, Tiegs G, Richard G, Wagener C, Bartsch U, Horst AK.

Invest Ophthalmol Vis Sci. 2014 Nov 18;55(12):7950-60. doi: 10.1167/iovs.13-13403.

PMID:
25406283
4.

Captopril and vascular endothelial growth factor in a mouse model of retinopathy.

Higgins RD, Yan Y, Geng Y, Sharma J, Barr SM.

Curr Eye Res. 2003 Aug;27(2):123-9.

PMID:
14632165
5.

Up-regulation of VEGF by retinoic acid during hyperoxia prevents retinal neovascularization and retinopathy.

Wang L, Shi P, Xu Z, Li J, Xie Y, Mitton K, Drenser K, Yan Q.

Invest Ophthalmol Vis Sci. 2014 May 27;55(7):4276-87. doi: 10.1167/iovs.14-14170.

PMID:
24867581
6.

Captopril improves retinal neovascularization via endothelin-1.

Tadesse M, Yan Y, Yossuck P, Higgins RD.

Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1867-72.

PMID:
11431455
7.

Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.

Gu X, Samuel S, El-Shabrawey M, Caldwell RB, Bartoli M, Marcus DM, Brooks SE.

Invest Ophthalmol Vis Sci. 2002 Feb;43(2):496-502.

PMID:
11818396
8.

The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.

Rabinowitz R, Katz G, Rosner M, Pri-Chen S, Spierer A.

Graefes Arch Clin Exp Ophthalmol. 2008 Jun;246(6):843-8. doi: 10.1007/s00417-008-0781-z. Epub 2008 Mar 15.

PMID:
18343940
9.

Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.

Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.

Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2175-82.

PMID:
15914639
10.

Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.

Kusari J, Padillo E, Zhou SX, Bai Y, Wang J, Song Z, Zhu M, Le YZ, Gil DW.

Invest Ophthalmol Vis Sci. 2011 Jul 20;52(8):5424-31. doi: 10.1167/iovs.10-6262.

11.

T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.

Banin E, Dorrell MI, Aguilar E, Ritter MR, Aderman CM, Smith AC, Friedlander J, Friedlander M.

Invest Ophthalmol Vis Sci. 2006 May;47(5):2125-34.

PMID:
16639024
12.

Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy.

Abdelsaid MA, Pillai BA, Matragoon S, Prakash R, Al-Shabrawey M, El-Remessy AB.

J Pharmacol Exp Ther. 2010 Jan;332(1):125-34. doi: 10.1124/jpet.109.157941. Epub 2009 Oct 8.

13.

A murine model for retinopathy of prematurity identifies endothelial cell proliferation as a potential mechanism for plus disease.

Guaiquil VH, Hewing NJ, Chiang MF, Rosenblatt MI, Chan RV, Blobel CP.

Invest Ophthalmol Vis Sci. 2013 Aug 7;54(8):5294-302. doi: 10.1167/iovs.12-11492.

14.

Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy.

Higgins RD, Yu K, Sanders RJ, Nandgaonkar BN, Rotschild T, Rifkin DB.

Curr Eye Res. 1999 Jan;18(1):20-7.

PMID:
10075199
15.

Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model.

Lange C, Ehlken C, Stahl A, Martin G, Hansen L, Agostini HT.

Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1205-11. doi: 10.1007/s00417-009-1116-4. Epub 2009 Jun 13.

PMID:
19526246
16.

Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy.

Fu ZJ, Li SY, Kociok N, Wong D, Chung SK, Lo AC.

Invest Ophthalmol Vis Sci. 2012 Aug 20;53(9):5698-712. doi: 10.1167/iovs.12-10122.

PMID:
22836764
17.

Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR).

Scott A, Powner MB, Fruttiger M.

Exp Eye Res. 2014 Mar;120:55-60. doi: 10.1016/j.exer.2013.12.020. Epub 2014 Jan 10.

PMID:
24418725
18.

Avastin treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity.

Rabinowitz R, Priel A, Rosner M, Pri-Chen S, Spierer A.

Curr Eye Res. 2012 Jul;37(7):624-9. doi: 10.3109/02713683.2012.669003. Epub 2012 May 11.

PMID:
22578253
19.

Genetic inactivation of the adenosine A2A receptor attenuates pathologic but not developmental angiogenesis in the mouse retina.

Liu XL, Zhou R, Pan QQ, Jia XL, Gao WN, Wu J, Lin J, Chen JF.

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6625-32. doi: 10.1167/iovs.09-4900. Epub 2010 Jul 7.

20.

Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration.

Suwanpradid J, Rojas M, Behzadian MA, Caldwell RW, Caldwell RB.

PLoS One. 2014 Nov 6;9(11):e110604. doi: 10.1371/journal.pone.0110604. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk